Global Bruton's Tyrosine Kinase (BTK) Inhibitors Market Growth (Status and Outlook) 2020-2025
COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.
According to this latest study, the 2020 growth of Bruton's Tyrosine Kinase (BTK) Inhibitors will have significant change from previous year. By the most conservative estimates of global Bruton's Tyrosine Kinase (BTK) Inhibitors market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. We give this scenario a XX% probability, where under the scenario the supply chain will start to recover and quarantines and travel bans will ease, over the Q2. Longer-term, the effect of COVID-19 will be felt throughout the year with some degree of harm done by the virus. Over the next five years the Bruton's Tyrosine Kinase (BTK) Inhibitors market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of Bruton's Tyrosine Kinase (BTK) Inhibitors market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Bruton's Tyrosine Kinase (BTK) Inhibitors, covering the supply chain analysis, impact assessment to the Bruton's Tyrosine Kinase (BTK) Inhibitors market size growth rate in several scenarios, and the measures to be undertaken by Bruton's Tyrosine Kinase (BTK) Inhibitors companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.
Irreversible Inhibitor
Reversible Inhibitor
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.
Chronic Lymphocytic Leukemia (cll)
Follicular Lymphoma
Mantle Cell Lymphoma
Marginal Zone Lymphoma
Small Lymphocytic Lymphoma
Waldenstrom Macroglobulinemia
Other Selective B Cell Malignancies
Chronic Graft-versus-host Disease
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Johnson & Johnson
INNOCARE
AstraZeneca
Sunesis
Takeda
Roche
AbbVie
Bristol- Myers Squibb
Biogen
Gilead Sciences
Carna Biosciences
Eternity Bioscience
Celgene Corporation
ACEA Biosciences
ArQule
Aptose Biosciences
KBP Biosciences
BeiGene
Acerta Pharma
Hanmi Pharmaceutical
X-Rx
Zhejiang DTRM Biopharma
Principia Biopharma
Pharmacyclics
Tolero
LSK BioPharma
Merck
Loxo Oncology
Ono Pharmaceutical
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Bruton's Tyrosine Kinase (BTK) Inhibitors market size by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Bruton's Tyrosine Kinase (BTK) Inhibitors market by identifying its various subsegments.
Focuses on the key global Bruton's Tyrosine Kinase (BTK) Inhibitors players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Bruton's Tyrosine Kinase (BTK) Inhibitors with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Bruton's Tyrosine Kinase (BTK) Inhibitors submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
1.7 What is the Impact of Covid-19 Outbreak On the Bruton's Tyrosine Kinase (BTK) Inhibitors?
1.7.1 Optimistic Scenario: COVID-19 Is Contained by May or June, with Normalcy Returning to Global Operations Through the End of Q2.
1.7.2 Conservative Scenario: COVID-19 Remains Prevalent, with Continued Impacts Lasting Into Q4.
1.7.3 Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size in 2020, by Scenario
1.7.4 Corporate Strategy the Manufacturers Should Be Thinking About Right Now
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size 2015-2025
2.1.2 Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size CAGR by Region
2.2 Bruton's Tyrosine Kinase (BTK) Inhibitors Segment by Type
2.2.1 Irreversible Inhibitor
2.2.2 Irreversible Inhibitor
2.3 Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size by Type
2.3.1 Global Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Market Share by Type (2015-2020)
2.3.2 Global Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Growth Rate by Type (2015-2020)
2.4 Bruton's Tyrosine Kinase (BTK) Inhibitors Segment by Application
2.4.1 Chronic Lymphocytic Leukemia (cll)
2.4.2 Follicular Lymphoma
2.4.3 Mantle Cell Lymphoma
2.4.4 Marginal Zone Lymphoma
2.4.5 Small Lymphocytic Lymphoma
2.4.6 Waldenstrom Macroglobulinemia
2.4.7 Other Selective B Cell Malignancies
2.4.8 Chronic Graft-versus-host Disease
2.4.9 Other
2.5 Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size by Application
2.5.1 Global Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Market Share by Application (2015-2020)
2.5.2 Global Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Growth Rate by Application (2015-2020)
3 Global Bruton's Tyrosine Kinase (BTK) Inhibitors by Players
3.1 Global Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Market Share by Players
3.1.1 Global Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size by Players (2018-2020)
3.1.2 Global Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Market Share by Players (2018-2020)
3.2 Global Bruton's Tyrosine Kinase (BTK) Inhibitors Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Bruton's Tyrosine Kinase (BTK) Inhibitors by Regions
4.1 Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size by Regions
4.2 Americas Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Growth
4.3 APAC Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Growth
4.4 Europe Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Growth
4.5 Middle East & Africa Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Growth
5 Americas
5.1 Americas Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size by Countries
5.2 Americas Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size by Type
5.3 Americas Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size by Regions
6.2 APAC Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size by Type
6.3 APAC Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Bruton's Tyrosine Kinase (BTK) Inhibitors by Countries
7.2 Europe Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size by Type
7.3 Europe Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Bruton's Tyrosine Kinase (BTK) Inhibitors by Countries
8.2 Middle East & Africa Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size by Type
8.3 Middle East & Africa Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Bruton's Tyrosine Kinase (BTK) Inhibitors Market Forecast
10.1 Global Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Forecast (2021-2025)
10.2 Global Bruton's Tyrosine Kinase (BTK) Inhibitors Forecast by Regions
10.2.1 Global Bruton's Tyrosine Kinase (BTK) Inhibitors Forecast by Regions (2021-2025)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Bruton's Tyrosine Kinase (BTK) Inhibitors Forecast by Type
10.8 Global Bruton's Tyrosine Kinase (BTK) Inhibitors Forecast by Application
11 Key Players Analysis
11.1 Johnson & Johnson
11.1.1 Company Details
11.1.2 Bruton's Tyrosine Kinase (BTK) Inhibitors Product Offered
11.1.3 Johnson & Johnson Bruton's Tyrosine Kinase (BTK) Inhibitors Revenue, Gross Margin and Market Share (2018-2020)
11.1.4 Main Business Overview
11.1.5 Johnson & Johnson News
11.2 INNOCARE
11.2.1 Company Details
11.2.2 Bruton's Tyrosine Kinase (BTK) Inhibitors Product Offered
11.2.3 INNOCARE Bruton's Tyrosine Kinase (BTK) Inhibitors Revenue, Gross Margin and Market Share (2018-2020)
11.2.4 Main Business Overview
11.2.5 INNOCARE News
11.3 AstraZeneca
11.3.1 Company Details
11.3.2 Bruton's Tyrosine Kinase (BTK) Inhibitors Product Offered
11.3.3 AstraZeneca Bruton's Tyrosine Kinase (BTK) Inhibitors Revenue, Gross Margin and Market Share (2018-2020)
11.3.4 Main Business Overview
11.3.5 AstraZeneca News
11.4 Sunesis
11.4.1 Company Details
11.4.2 Bruton's Tyrosine Kinase (BTK) Inhibitors Product Offered
11.4.3 Sunesis Bruton's Tyrosine Kinase (BTK) Inhibitors Revenue, Gross Margin and Market Share (2018-2020)
11.4.4 Main Business Overview
11.4.5 Sunesis News
11.5 Takeda
11.5.1 Company Details
11.5.2 Bruton's Tyrosine Kinase (BTK) Inhibitors Product Offered
11.5.3 Takeda Bruton's Tyrosine Kinase (BTK) Inhibitors Revenue, Gross Margin and Market Share (2018-2020)
11.5.4 Main Business Overview
11.5.5 Takeda News
11.6 Roche
11.6.1 Company Details
11.6.2 Bruton's Tyrosine Kinase (BTK) Inhibitors Product Offered
11.6.3 Roche Bruton's Tyrosine Kinase (BTK) Inhibitors Revenue, Gross Margin and Market Share (2018-2020)
11.6.4 Main Business Overview
11.6.5 Roche News
11.7 AbbVie
11.7.1 Company Details
11.7.2 Bruton's Tyrosine Kinase (BTK) Inhibitors Product Offered
11.7.3 AbbVie Bruton's Tyrosine Kinase (BTK) Inhibitors Revenue, Gross Margin and Market Share (2018-2020)
11.7.4 Main Business Overview
11.7.5 AbbVie News
11.8 Bristol- Myers Squibb
11.8.1 Company Details
11.8.2 Bruton's Tyrosine Kinase (BTK) Inhibitors Product Offered
11.8.3 Bristol- Myers Squibb Bruton's Tyrosine Kinase (BTK) Inhibitors Revenue, Gross Margin and Market Share (2018-2020)
11.8.4 Main Business Overview
11.8.5 Bristol- Myers Squibb News
11.9 Biogen
11.9.1 Company Details
11.9.2 Bruton's Tyrosine Kinase (BTK) Inhibitors Product Offered
11.9.3 Biogen Bruton's Tyrosine Kinase (BTK) Inhibitors Revenue, Gross Margin and Market Share (2018-2020)
11.9.4 Main Business Overview
11.9.5 Biogen News
11.10 Gilead Sciences
11.10.1 Company Details
11.10.2 Bruton's Tyrosine Kinase (BTK) Inhibitors Product Offered
11.10.3 Gilead Sciences Bruton's Tyrosine Kinase (BTK) Inhibitors Revenue, Gross Margin and Market Share (2018-2020)
11.10.4 Main Business Overview
11.10.5 Gilead Sciences News
11.11 Carna Biosciences
11.12 Eternity Bioscience
11.13 Celgene Corporation
11.14 ACEA Biosciences
11.15 ArQule
11.16 Aptose Biosciences
11.17 KBP Biosciences
11.18 BeiGene
11.19 Acerta Pharma
11.20 Hanmi Pharmaceutical
11.21 X-Rx
11.22 Zhejiang DTRM Biopharma
11.23 Principia Biopharma
11.24 Pharmacyclics
11.25 Tolero
11.26 LSK BioPharma
11.27 Merck
11.28 Loxo Oncology
11.29 Ono Pharmaceutical
12 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size in 2020, by Scenario
Table 2. COVID-19: Measures to be Undertaken by Bruton's Tyrosine Kinase (BTK) Inhibitors Companies
Table 3. Research Methodology
Table 4. Data Source
Table 5. Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size CAGR by Region 2015-2025 ($ Millions)
Table 6. Major Players of Irreversible Inhibitor
Table 7. Major Players of Reversible Inhibitor
Table 8. Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size by Type (2014-2019) ($ Millions)
Table 9. Global Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Market Share by Type (2015-2020)
Table 10. Global Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size by Application (2015-2020) ($ Millions)
Table 11. Global Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Market Share by Application (2015-2020)
Table 12. Global Bruton's Tyrosine Kinase (BTK) Inhibitors Revenue by Players (2018-2020) ($ Millions)
Table 13. Global Bruton's Tyrosine Kinase (BTK) Inhibitors Revenue Market Share by Players (2018-2020)
Table 14. Global Bruton's Tyrosine Kinase (BTK) Inhibitors Key Players Head office and Products Offered
Table 15. Bruton's Tyrosine Kinase (BTK) Inhibitors Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size by Regions 2015-2020 ($ Millions)
Table 19. Global Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Market Share by Regions 2015-2020
Table 20. Americas Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size by Countries (2015-2020) ($ Millions)
Table 21. Americas Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Market Share by Countries (2015-2020)
Table 22. Americas Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size by Type (2015-2020) ($ Millions)
Table 23. Americas Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Market Share by Type (2015-2020)
Table 24. Americas Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size by Application (2015-2020) ($ Millions)
Table 25. Americas Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Market Share by Application (2015-2020)
Table 26. APAC Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size by Regions (2015-2020) ($ Millions)
Table 27. APAC Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Market Share by Regions (2015-2020)
Table 28. APAC Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size by Type (2015-2020) ($ Millions)
Table 29. APAC Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Market Share by Type (2015-2020)
Table 30. APAC Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size by Application (2015-2020) ($ Millions)
Table 31. APAC Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Market Share by Application (2015-2020)
Table 32. Europe Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size by Countries (2015-2020) ($ Millions)
Table 33. Europe Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Market Share by Countries (2015-2020)
Table 34. Europe Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size by Type (2015-2020) ($ Millions)
Table 35. Europe Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Market Share by Type (2015-2020)
Table 36. Europe Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size by Application (2015-2020) ($ Millions)
Table 37. Europe Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Market Share by Application (2015-2020)
Table 38. Middle East & Africa Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size by Countries (2015-2020) ($ Millions)
Table 39. Middle East & Africa Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Market Share by Countries (2015-2020)
Table 40. Middle East & Africa Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size by Type (2015-2020) ($ Millions)
Table 41. Middle East & Africa Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Market Share by Type (2015-2020)
Table 42. Middle East & Africa Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size by Application (2015-2020) ($ Millions)
Table 43. Middle East & Africa Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Market Share by Application (2015-2020)
Table 44. Key and Potential Regions of Bruton's Tyrosine Kinase (BTK) Inhibitors
Table 45. Key Application and Potential Industries of Bruton's Tyrosine Kinase (BTK) Inhibitors
Table 46. Key Challenges of Bruton's Tyrosine Kinase (BTK) Inhibitors
Table 47. Key Trends of Bruton's Tyrosine Kinase (BTK) Inhibitors
Table 48. Global Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Forecast by Regions (2021-2025) ($ Millions)
Table 49. Global Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Market Share Forecast by Regions
Table 50. Global Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Forecast by Type (2021-2025) ($ Millions)
Table 51. Global Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Market Share Forecast by Type (2021-2025)
Table 52. Global Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Forecast by Application (2021-2025) ($ Millions)
Table 53. Global Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Market Share Forecast by Application (2021-2025)
Table 54. Johnson & Johnson Details, Company Total Revenue (in $ million), Head Office, Bruton's Tyrosine Kinase (BTK) Inhibitors Major Market Areas and Its Competitors
Table 55. Johnson & Johnson Bruton's Tyrosine Kinase (BTK) Inhibitors Product Offered
Table 56. Johnson & Johnson Bruton's Tyrosine Kinase (BTK) Inhibitors Revenue and Gross Margin (2018-2020E)
Table 57. Johnson & Johnson Main Business
Table 58. Johnson & Johnson Latest Developments
Table 59. INNOCARE Details, Company Total Revenue (in $ million), Head Office, Bruton's Tyrosine Kinase (BTK) Inhibitors Major Market Areas and Its Competitors
Table 60. INNOCARE Bruton's Tyrosine Kinase (BTK) Inhibitors Product Offered
Table 61. INNOCARE Main Business
Table 62. INNOCARE Bruton's Tyrosine Kinase (BTK) Inhibitors Revenue and Gross Margin (2018-2020E)
Table 63. INNOCARE Latest Developments
Table 64. AstraZeneca Details, Company Total Revenue (in $ million), Head Office, Bruton's Tyrosine Kinase (BTK) Inhibitors Major Market Areas and Its Competitors
Table 65. AstraZeneca Bruton's Tyrosine Kinase (BTK) Inhibitors Product Offered
Table 66. AstraZeneca Main Business
Table 67. AstraZeneca Bruton's Tyrosine Kinase (BTK) Inhibitors Revenue and Gross Margin (2018-2020E)
Table 68. AstraZeneca Latest Developments
Table 69. Sunesis Details, Company Total Revenue (in $ million), Head Office, Bruton's Tyrosine Kinase (BTK) Inhibitors Major Market Areas and Its Competitors
Table 70. Sunesis Bruton's Tyrosine Kinase (BTK) Inhibitors Product Offered
Table 71. Sunesis Main Business
Table 72. Sunesis Bruton's Tyrosine Kinase (BTK) Inhibitors Revenue and Gross Margin (2018-2020E)
Table 73. Sunesis Latest Developments
Table 74. Takeda Details, Company Total Revenue (in $ million), Head Office, Bruton's Tyrosine Kinase (BTK) Inhibitors Major Market Areas and Its Competitors
Table 75. Takeda Bruton's Tyrosine Kinase (BTK) Inhibitors Product Offered
Table 76. Takeda Main Business
Table 77. Takeda Bruton's Tyrosine Kinase (BTK) Inhibitors Revenue and Gross Margin (2018-2020E)
Table 78. Takeda Latest Developments
Table 79. Roche Details, Company Total Revenue (in $ million), Head Office, Bruton's Tyrosine Kinase (BTK) Inhibitors Major Market Areas and Its Competitors
Table 80. Roche Bruton's Tyrosine Kinase (BTK) Inhibitors Product Offered
Table 81. Roche Main Business
Table 82. Roche Bruton's Tyrosine Kinase (BTK) Inhibitors Revenue and Gross Margin (2018-2020E)
Table 83. Roche Latest Developments
Table 84. AbbVie Details, Company Total Revenue (in $ million), Head Office, Bruton's Tyrosine Kinase (BTK) Inhibitors Major Market Areas and Its Competitors
Table 85. AbbVie Bruton's Tyrosine Kinase (BTK) Inhibitors Product Offered
Table 86. AbbVie Main Business
Table 87. AbbVie Bruton's Tyrosine Kinase (BTK) Inhibitors Revenue and Gross Margin (2018-2020E)
Table 88. AbbVie Latest Developments
Table 89. Bristol- Myers Squibb Details, Company Total Revenue (in $ million), Head Office, Bruton's Tyrosine Kinase (BTK) Inhibitors Major Market Areas and Its Competitors
Table 90. Bristol- Myers Squibb Bruton's Tyrosine Kinase (BTK) Inhibitors Product Offered
Table 91. Bristol- Myers Squibb Main Business
Table 92. Bristol- Myers Squibb Bruton's Tyrosine Kinase (BTK) Inhibitors Revenue and Gross Margin (2018-2020E)
Table 93. Bristol- Myers Squibb Latest Developments
Table 94. Biogen Details, Company Total Revenue (in $ million), Head Office, Bruton's Tyrosine Kinase (BTK) Inhibitors Major Market Areas and Its Competitors
Table 95. Biogen Bruton's Tyrosine Kinase (BTK) Inhibitors Product Offered
Table 96. Biogen Main Business
Table 97. Biogen Bruton's Tyrosine Kinase (BTK) Inhibitors Revenue and Gross Margin (2018-2020E)
Table 98. Biogen Latest Developments
Table 99. Gilead Sciences Details, Company Total Revenue (in $ million), Head Office, Bruton's Tyrosine Kinase (BTK) Inhibitors Major Market Areas and Its Competitors
Table 100. Gilead Sciences Bruton's Tyrosine Kinase (BTK) Inhibitors Product Offered
Table 101. Gilead Sciences Main Business
Table 102. Gilead Sciences Bruton's Tyrosine Kinase (BTK) Inhibitors Revenue and Gross Margin (2018-2020E)
Table 103. Gilead Sciences Latest Developments
Table 104. Carna Biosciences Details, Company Total Revenue (in $ million), Head Office, Bruton's Tyrosine Kinase (BTK) Inhibitors Major Market Areas and Its Competitors
Table 105. Eternity Bioscience Details, Company Total Revenue (in $ million), Head Office, Bruton's Tyrosine Kinase (BTK) Inhibitors Major Market Areas and Its Competitors
Table 106. Celgene Corporation Details, Company Total Revenue (in $ million), Head Office, Bruton's Tyrosine Kinase (BTK) Inhibitors Major Market Areas and Its Competitors
Table 107. ACEA Biosciences Details, Company Total Revenue (in $ million), Head Office, Bruton's Tyrosine Kinase (BTK) Inhibitors Major Market Areas and Its Competitors
Table 108. ArQule Details, Company Total Revenue (in $ million), Head Office, Bruton's Tyrosine Kinase (BTK) Inhibitors Major Market Areas and Its Competitors
Table 109. Aptose Biosciences Details, Company Total Revenue (in $ million), Head Office, Bruton's Tyrosine Kinase (BTK) Inhibitors Major Market Areas and Its Competitors
Table 110. KBP Biosciences Details, Company Total Revenue (in $ million), Head Office, Bruton's Tyrosine Kinase (BTK) Inhibitors Major Market Areas and Its Competitors
Table 111. BeiGene Details, Company Total Revenue (in $ million), Head Office, Bruton's Tyrosine Kinase (BTK) Inhibitors Major Market Areas and Its Competitors
Table 112. Acerta Pharma Details, Company Total Revenue (in $ million), Head Office, Bruton's Tyrosine Kinase (BTK) Inhibitors Major Market Areas and Its Competitors
Table 113. Hanmi Pharmaceutical Details, Company Total Revenue (in $ million), Head Office, Bruton's Tyrosine Kinase (BTK) Inhibitors Major Market Areas and Its Competitors
Table 114. X-Rx Details, Company Total Revenue (in $ million), Head Office, Bruton's Tyrosine Kinase (BTK) Inhibitors Major Market Areas and Its Competitors
Table 115. Zhejiang DTRM Biopharma Details, Company Total Revenue (in $ million), Head Office, Bruton's Tyrosine Kinase (BTK) Inhibitors Major Market Areas and Its Competitors
Table 116. Principia Biopharma Details, Company Total Revenue (in $ million), Head Office, Bruton's Tyrosine Kinase (BTK) Inhibitors Major Market Areas and Its Competitors
Table 117. Pharmacyclics Details, Company Total Revenue (in $ million), Head Office, Bruton's Tyrosine Kinase (BTK) Inhibitors Major Market Areas and Its Competitors
Table 118. Tolero Details, Company Total Revenue (in $ million), Head Office, Bruton's Tyrosine Kinase (BTK) Inhibitors Major Market Areas and Its Competitors
Table 119. LSK BioPharma Details, Company Total Revenue (in $ million), Head Office, Bruton's Tyrosine Kinase (BTK) Inhibitors Major Market Areas and Its Competitors
Table 120. Merck Details, Company Total Revenue (in $ million), Head Office, Bruton's Tyrosine Kinase (BTK) Inhibitors Major Market Areas and Its Competitors
Table 121. Loxo Oncology Details, Company Total Revenue (in $ million), Head Office, Bruton's Tyrosine Kinase (BTK) Inhibitors Major Market Areas and Its Competitors
Table 122. Ono Pharmaceutical Details, Company Total Revenue (in $ million), Head Office, Bruton's Tyrosine Kinase (BTK) Inhibitors Major Market Areas and Its Competitors
List of Figures
Figure 1. Bruton's Tyrosine Kinase (BTK) Inhibitors Report Years Considered
Figure 2. Market Research Methodology
Figure 3. Global Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Growth Rate 2015-2025 ($ Millions)
Figure 4. Global Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Market Share by Type (2015-2020)
Figure 5. Global Irreversible Inhibitor Market Size Growth Rate
Figure 6. Global Reversible Inhibitor Market Size Growth Rate
Figure 7. Bruton's Tyrosine Kinase (BTK) Inhibitors in Chronic Lymphocytic Leukemia (cll)
Figure 8. Global Bruton's Tyrosine Kinase (BTK) Inhibitors Market: Chronic Lymphocytic Leukemia (cll) (2015-2020) ($ Millions)
Figure 9. Bruton's Tyrosine Kinase (BTK) Inhibitors in Follicular Lymphoma
Figure 10. Global Bruton's Tyrosine Kinase (BTK) Inhibitors Market: Follicular Lymphoma (2015-2020) ($ Millions)
Figure 11. Bruton's Tyrosine Kinase (BTK) Inhibitors in Mantle Cell Lymphoma
Figure 12. Global Bruton's Tyrosine Kinase (BTK) Inhibitors Market: Mantle Cell Lymphoma (2015-2020) ($ Millions)
Figure 13. Global Mantle Cell Lymphoma YoY Growth ($ Millions)
Figure 14. Bruton's Tyrosine Kinase (BTK) Inhibitors in Marginal Zone Lymphoma
Figure 15. Global Bruton's Tyrosine Kinase (BTK) Inhibitors Market: Marginal Zone Lymphoma (2015-2020) ($ Millions)
Figure 16. Global Marginal Zone Lymphoma YoY Growth ($ Millions)
Figure 17. Bruton's Tyrosine Kinase (BTK) Inhibitors in Small Lymphocytic Lymphoma
Figure 18. Global Bruton's Tyrosine Kinase (BTK) Inhibitors Market: Small Lymphocytic Lymphoma (2015-2020) ($ Millions)
Figure 19. Global Small Lymphocytic Lymphoma YoY Growth ($ Millions)
Figure 20. Global Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Market Share by Application in 2019
Figure 21. Global Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Market Share by Regions 2015-2020
Figure 22. Americas Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size 2015-2020 ($ Millions)
Figure 23. APAC Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size 2015-2020 ($ Millions)
Figure 24. Europe Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size 2015-2020 ($ Millions)
Figure 25. Middle East & Africa Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size 2015-2020 ($ Millions)
Figure 26. Americas Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Market Share by Countries in 2019
Figure 27. Americas Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Market Share by Type in 2019
Figure 28. Americas Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Market Share by Application in 2019
Figure 29. United States Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Growth 2015-2020 ($ Millions)
Figure 30. Canada Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Growth 2015-2020 ($ Millions)
Figure 31. Mexico Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Growth 2015-2020 ($ Millions)
Figure 32. APAC Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Market Share by Regions in 2019
Figure 33. APAC Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Market Share by Type in 2019
Figure 34. APAC Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Market Share by Application in 2019
Figure 35. China Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Growth 2015-2020 ($ Millions)
Figure 36. Japan Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Growth 2015-2020 ($ Millions)
Figure 37. Korea Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Growth 2015-2020 ($ Millions)
Figure 38. Southeast Asia Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Growth 2015-2020 ($ Millions)
Figure 39. India Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Growth 2015-2020 ($ Millions)
Figure 40. Australia Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Growth 2015-2020 ($ Millions)
Figure 41. Europe Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Market Share by Countries in 2019
Figure 42. Europe Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Market Share by Type in 2019
Figure 43. Europe Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Market Share by Application in 2019
Figure 44. Germany Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Growth 2015-2020 ($ Millions)
Figure 45. France Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Growth 2015-2020 ($ Millions)
Figure 46. UK Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Growth 2015-2020 ($ Millions)
Figure 47. Italy Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Growth 2015-2020 ($ Millions)
Figure 48. Russia Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Growth 2015-2020 ($ Millions)
Figure 49. Spain Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Growth 2015-2020 ($ Millions)
Figure 50. Middle East & Africa Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Market Share by Countries in 2019
Figure 51. Middle East & Africa Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Market Share by Type in 2019
Figure 52. Middle East & Africa Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Market Share by Application in 2019
Figure 53. Egypt Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Growth 2015-2020 ($ Millions)
Figure 54. South Africa Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Growth 2015-2020 ($ Millions)
Figure 55. Israel Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Growth 2015-2020 ($ Millions)
Figure 56. Turkey Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Growth 2015-2020 ($ Millions)
Figure 57. GCC Countries Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size Growth 2015-2020 ($ Millions)
Figure 58. Global Bruton's Tyrosine Kinase (BTK) Inhibitors arket Size Forecast (2021-2025) ($ Millions)
Figure 59. Americas Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size 2021-2025 ($ Millions)
Figure 60. APAC Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size 2021-2025 ($ Millions)
Figure 61. Europe Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size 2021-2025 ($ Millions)
Figure 62. Middle East & Africa Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size 2021-2025 ($ Millions)
Figure 63. United States Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size 2021-2025 ($ Millions)
Figure 64. Canada Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size 2021-2025 ($ Millions)
Figure 65. Mexico Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size 2021-2025 ($ Millions)
Figure 66. Brazil Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size 2021-2025 ($ Millions)
Figure 67. China Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size 2021-2025 ($ Millions)
Figure 68. Japan Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size 2021-2025 ($ Millions)
Figure 69. Korea Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size 2021-2025 ($ Millions)
Figure 70. Southeast Asia Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size 2021-2025 ($ Millions)
Figure 71. India Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size 2021-2025 ($ Millions)
Figure 72. Australia Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size 2021-2025 ($ Millions)
Figure 73. Germany Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size 2021-2025 ($ Millions)
Figure 74. France Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size 2021-2025 ($ Millions)
Figure 75. UK Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size 2021-2025 ($ Millions)
Figure 76. Italy Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size 2021-2025 ($ Millions)
Figure 77. Russia Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size 2021-2025 ($ Millions)
Figure 78. Spain Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size 2021-2025 ($ Millions)
Figure 79. Egypt Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size 2021-2025 ($ Millions)
Figure 80. South Africa Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size 2021-2025 ($ Millions)
Figure 81. Israel Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size 2021-2025 ($ Millions)
Figure 82. Turkey Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size 2021-2025 ($ Millions)
Figure 83. GCC Countries Bruton's Tyrosine Kinase (BTK) Inhibitors Market Size 2021-2025 ($ Millions)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets